You are here: Industry Insights > AstraZeneca

News List

AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate expresspharma
July 16, 2020
The collaboration is part of the US government’s Operation Warp Speed to accelerate the development of COVID-19 vaccines and treatments.
Positive news on Oxford/AstraZeneca COVID-19 vaccine could come soon: ITV expresspharma
July 16, 2020
The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results.
US priority review for AZ' Brilinta/aspirin combination pharmatimes
July 14, 2020
The US Food and Drug Administration has agreed to a speedy review of AstraZeneca's Brilinta (ticagrelor) for the reduction of subsequent stroke in patients who have experienced an acute ischaemic stroke or transient ischaemic attack (TIA).
Selumetinib Granted Orphan Drug Designation in Japan for Neurofibromatosis Type 1 americanpharmaceuticalreview
July 09, 2020
AstraZeneca announced selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease.
Astrazeneca’s Dapagliflozin gets DCGI nod for treatment of heart failure expresspharma
July 06, 2020
Dapagliflozin (Forxiga) is an SGLT-2 inhibitor that can reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with HFrEF.
Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial pharmatimes
June 30, 2020
AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) significantly cut the rate of moderate or severe exacerbations compared with two dual-combination therapies in patients with ...
Brazil signs agreement to produce AstraZeneca’s COVID-19 vaccine candidate expresspharma
June 29, 2020
Brazil has signed a $127 million agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the COVID-19 pandemic.
Japan’s Daiichi Sankyo in talks with AstraZeneca for Covid-19 vaccine pharmaceutical-technology
June 28, 2020
Japanese pharmaceutical company Daiichi Sankyo has entered an agreement for discussions with AstraZeneca for the supply of a Covid-19 vaccine candidate, being developed in alliance with the University of Oxford, in Japan.
AstraZeneca eyes three-drug inhaler opportunity after trial results expresspharma
June 28, 2020
AstraZeneca said that the ETHOS trial of triple-drug therapy c formerly known as PT010, helped patients suffering from chronic obstructive pulmonary disease.
AstraZeneca commits to supply Europe with 400 million doses of COVID-19 vaccine candidate europeanpharmaceuticalreview
June 22, 2020
AstraZeneca plans to produce up to 400 million doses of the University of Oxford’s COVID-19 vaccine candidate, with deliveries to begin by the end of the year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page